Celecoxib
Cat.No:IC0230 Solarbio
CAS:169590-42-5
Molecular Formula:C17H14F3N3O2S
Molecular Weight:381.37
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Immunology & Inflammation > CelecoxibCAS:169590-42-5
Molecular Formula:C17H14F3N3O2S
Molecular Weight:381.37
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:White to off-white Solid
Qty:
Size:
| CAS | 169590-42-5 |
| Name | Celecoxib |
| Molecular Formula | C17H14F3N3O2S |
| Molecular Weight | 381.37 |
| Solubility | Soluble in DMSO ≥5mg/mL |
| Purity | HPLC≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
| EC | EINECS 685-962-5 |
| MDL | MFCD00941298 |
| SMILES | CC1=CC=C(C=C1)C2=CC(C(F)(F)F)=NN2C3=CC=C(C=C3)S(=O)(N)=O |
| InChIKey | RZEKVGVHFLEQIL-UHFFFAOYSA-N |
| InChI | InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25) |
| PubChem CID | 2662 |
| Target Point | COX-2 |
| Passage | Immunology & Inflammation |
| Background | It is a selective COX-2 inhibitor that inhibits prostaglandin production by inhibiting COX-2. |
| Biological Activity | Celecoxib 是一种选择性的 COX-2 抑制剂, IC50 为 40 nM[1-5]。 |
| IC50 | COX-2:40nM (IC50) COX-1:15μM (IC50) [1-5] |
| Data Literature Source | [1]. Penning TD, et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5- (4-methylphenyl) -3- (trifluoromethyl) -1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib) . J Med Chem. 1997 [2]. Liu DB, et al. Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation. Acta Pharmacol Sin. 2012 May; 33 (5) :682-90. [3]. Suri A, et al. The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer. Oncotarget. 2016 Apr 8. [4]. Hou XL, et al. Combination of fasudil and celecoxib promotes the recovery of injured spinal cord in rats better than celecoxib or fasudil alone. Neural Regen Res. 2015 Nov; 10 (11) :1836-40. [5]. Liu C, et al. Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux. Sci Rep. 2018 Mar 7; 8 (1) :4108. |
| Unit | Bottle |
| Specification | 10mM*1mL in DMSO 50mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Potential applications of multifunctional mesoporous carbon nanoplatform for tumor microenvironment improving by combined chemo-/phototherapy
Click to check >>Author:A Y Z ; A J Z ; B G H ;et al
IF:11.3070
Publish_to:Carbon
PMID:
Identification of Precise Therapeutic Targets and Characteristic Prognostic Genes Based on Immune Gene Characteristics in Uveal Melanoma
Click to check >>Author:Zhang Z; Su J; Li L; Du W
IF:6.0810
Publish_to:Front Cell Dev Biol
PMID:34124047
Screening cyclooxygenase-2 inhibitors from Andrographis paniculata to treat inflammation based on bio-affinity ultrafiltration coupled with UPLC-Q-TOF-MS.
Click to check >>Author:Jiao J, Yang Y, Wu Z, Li B, Zheng Q, Wei S, Wang Y
IF:2.7660
Publish_to:Fitoterapia
PMID:31319108
Manual Download